CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Versant Venture Management, LLC's Holding History (CIK: 0001560009)

Note: Option positions (PUT/CALL) are excluded.

Q1 2022
Shares 410,360 Value ($000) $9,007 Avg Close $20.24 Range $16.53 - $28.95
Q4 2021
Shares 410,360 Value ($000) $11,658 Avg Close $24.65 Range $18.97 - $28.82
Q3 2021
Shares 820,720 Value ($000) $17,276 Avg Close $20.92 Range $16.68 - $25.50
Q2 2021
Shares 820,720 Value ($000) $15,471 Avg Close $17.57 Range $15.15 - $21.64
Q1 2021
Shares 2,030,616 Value ($000) $31,028 Avg Close $15.50 Range $13.29 - $18.09
Q4 2020
Shares 2,030,616 Value ($000) $28,652 Avg Close $13.93 Range $11.61 - $17.84
Q3 2020
Shares 2,030,616 Value ($000) $31,820 Avg Close $15.29 Range $13.12 - $18.12
Q2 2020
Shares 2,030,616 Value ($000) $35,576,392 Avg Close $17.05 Range $12.50 - $23.70